[ad_1]
June 28, 2025 is at 10:52
Vegovi, a weight -drug drug that reduces cardiovascular risks in obese individuals, launched in India on 24 June. Experts broke its benefits and risk.
The passion with weight loss injection is still getting stronger. Last year, celebrities such as social media frenzy and clouded trainer, Lizo, and Amy Shumor accepted to use it around the ozmpic, and when Maunzaro (Elon Musk revealed that he used it too!) Arrived in India in this march, a new contenders on the block: Vegovi. At the beginning of this week (24 June), Danish pharmaceutical giant Novo Nordisk launched this much awaited drug in India. But does it make it different from their predecessors, and why is everyone talking about it? Wagovi is designed for long -term weight management and to help reduce the risk of severe cardiovascular events in people living with obesity. It comes with five dosage options in a smooth, once weekly pen device: 0.25 mg, 0.5 ml, 1 mg, 1.7 mg, and 2.4 mg maintenance doses of 2.4 mg.
How does this work?
Similar to ozmpic and munjaro, this new weight loss drug is also a prescription-drug for adults that are thick or overweight and also have at least one weight related health condition, such as hypertension, type 2 diabetes or high cholesterol. “The active ingredient in the vegovi is semaglutide, which is a synthetic version of a naturally occurred hormone called GLP-1 (Glucagon-like Peptide-1). This hormone is released in the intestine in response to food intake and helps to regulate hunger and food intake,” Dr. Kashish Gupta informs the counselor.
In short, semaglutide helps you feel as soon as possible, slows down digestion and reduces appetite. These effects can reduce calorie intake over time and after all, weight loss. It can also improve blood sugar levels and help reduce the risk of heart issues in some individuals, especially type 2 diabetes.
Who can use it?
A dietist Dr. in Diet Clinics. According to Anjana Kalia, it is for adults with body mass index (BMI) (BMI) of 30 or above, or if there is a related health problem if 27 and above. “But these are not a miraculous solution. The decision to use it should always be taken with a qualified doctor after assessing medical history and risks,” she warns.
Whom should it be avoided?
People who have a personal or family history of marrow thyroid carcinoma, multiple endocrine neoplasia syndrome, they have pancreatitis or severe digestive disorders, pregnant, breastfeeding, breastfeeding or conceiving plan, food disorders, or allergic or its components. These drugs should be taken in full consultation with your medical businessman.
Vegovi vs Maunjaro vs Ozmpic
1. Vegova
- Active component: semglutide
- Accepted for: weight loss
- Dosage: weekly weekly
- Benefits: Helps regulating blood sugar levels, reduces the risk of heart events
- Side effects: nausea, diarrhea, vomiting
- price: 0.25mg, 0.5mg, and 1mg dosage and 17,345 per month for and 24,280 and 26,050 per month for 1.7mg and 2.4mg doses respectively.
2. Mounaro
- Active component: tirzepatide
- Accepted for: Type 2 Diabetes
- Dosage: weekly weekly
- Benefits: Helps regulating blood sugar levels, improves insulin sensitivity
- Side Effects: Nausea, diarrhea, vomiting and pancreatitis or thyroid issues in rare cases
- price: 4,375 ($ 50.67) for 5 mg vial, 3,500 ($ 40.54) for 2.5mg vial.
3. Ozmpic
- Active component: semglutide
- Accepted for: Type 2 Diabetes
- Dosage: weekly weekly
- Benefits: Helps regulating blood sugar levels, reduces appetite
- Side Effects: Nausea, diarrhea, stomach upset
- Price: may cost between injected ozmpic 8,000 and 20,000 a shot.
[ad_2]


